Basel
Switzerland
15
2023-08-10
13
2025-07-15
These are the the leading inventors for applications assigned to UNIVERSITAET BASEL:
UNIVERSITAET BASEL based in Basel, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Virulence Attenuated Bacteria Based Protein Delivery
#2 | 2022-06-09 β Patent 11,992,467 granted on 2024-05-28Promotion of lymphatic function
#3 | 2021-05-27 β Patent 12,091,670 granted on 2024-09-17Bacteria-based protein delivery
#4 | 2020-05-14PROMOTION OF LYMPHATIC FUNCTION
#5 | 2020-04-23 β Patent 11,518,789 granted on 2022-12-06Virulence attenuated bacteria based protein delivery
#6 | 2019-01-17 β Patent 10,766,874 granted on 2020-09-08Manufacturing process for triazine, pyrimidine and pyridine derivatives
#7 | 2019-01-17 β Patent 11,166,987 granted on 2021-11-09Virulence attenuated bacteria for treatment of malignant solid tumors
#8 | 2018-02-15 β Patent 10,537,408 granted on 2020-01-21Dental implant
#9 | 2017-07-13 β Patent 10,889,823 granted on 2021-01-12Bacteria-based protein delivery
#10 | 2017-02-09 β Patent 10,100,031 granted on 2018-10-16Manufacturing process for triazine, pyrimidine and pyridine derivatives
#11 | 2017-01-26 β Patent 9,994,605 granted on 2018-06-12Carbohydrate ligands that bind to IgM antibodies against myelin-associated glycoprotein
#12 | 2016-12-22PROMOTION OF LYMPHATIC FUNCTION
#13 | 2016-08-25 β Patent 9,556,203 granted on 2017-01-31Conformationally restricted P13K and mTOR inhibitors
#14 | 2013-03-07 β Patent 8,703,139 granted on 2014-04-22Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases
#15 | 2011-02-24 β Patent 8,252,908 granted on 2012-08-28Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases
Also check out UNIVERSITAET BASEL's (Basel, Switzerland) applicant profile with 9 patent applications submitted.
12693 β